Mdma molecule:

Image from PubChem

Mdma Clinical Trials


Pharmacological Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy): Pharmacodynamics (PD) and Pharmacokinetics (PK)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00990067

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Completed

Start Date: November 2009

Last Update: January 25, 2013

Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary: The purpose of this study is to determinate the effect of a pre-treatment with the combined serotonin (5-HT) and norepinephrine (NE) transport blocker duloxetine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). The investigators hypothesize that duloxetine will attenuate the subjective and cardiovascular response to MDMA.

Conditions:
  • Mood Disorder
  • Substance-Related Disorders
  • Amphetamine-Related Disorders


Total execution time in seconds: 0.20632410049438